A Study of Subcutaneous Lecanemab in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 7, 2021

Primary Completion Date

December 7, 2021

Study Completion Date

December 7, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

Lecanemab

Lecanemab IV infusion.

DRUG

Lecanemab

Lecanemab SC injection.

Trial Locations (1)

Anaheim Clinical Trials, Anaheim

All Listed Sponsors

lead

Eisai Inc.

INDUSTRY

NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants | Biotech Hunter | Biotech Hunter